The George Institute For Global Health
United Kingdom

News and Events

Monday, 25 November, 2019 - 09:00 to Friday, 29 November, 2019 - 17:00

Visthar, Bangalore, India

Tuesday, 15 October, 2019 - 09:30 to 16:30

ISI, Lodhi Road, New Delhi, India

Authored by Mercian Daniel, Program Manager, Mental Health, The George Institute India. Views expressed are personal.


Cardiovascular disease claims the most lives of any illness. Ahead of World Heart Day on September 29, we offer insights to debunk popular assumptions that affect advances in knowledge and improvements in health.

Mental Health

Mental health problems are some of the most challenging areas of health, but there are steps we can take to ensure they get the necessary attention – and a place within Universal Health Coverage (UHC). Ahead of the UN High-Level Meeting on UHC being held on 23 September, Prof Shekhar Saxena, Distinguished Fellow of The George Institute for Global Health and past Director of the Department of Mental Health and Substance Abuse at World Health Organisation explains why we need to remember the ‘five I’s’ to support implementation.

Media release: 

NEW DELHI, SEPT 10. Compared with usual care, the triple-pill strategy is cost-effective for patients with mild-to-moderate hypertension. Scaled up investment in the triple pill for hypertension management should be supported to address the high population burden of cardiovascular disease.

Media release: 

NEW DELHI, SEPT 10, Improved education of healthcare providers and follow-up of women with hypertensive disorders and diabetes during pregnancy are needed to limit future risk of cardio metabolic disease, finds new research from The George Institute for Global Health.

Media release: 

Kolkata, Sept 5. A study being conducted jointly by The George Institute for Global Health and the Child in Need Institute in the Sundarbans region of West Bengal has revealed that drowning is major cause of child mortality in the region.

Media release: 

SYDNEY, SEPT 6 - A new meta-analysis published in Lancet Diabetes and Endocrinology today has found that SGLT2 inhibitors can reduce the risk of dialysis, transplantation, or death due to kidney disease in people with type 2 diabetes.

Media release: 

Low cost mobile technology developed in Australia and piloted in India shifts the dial on cardiovascular risk in rural Indonesia

NEW DELHI, AUG 29.  An Indo-Australian-developed mobile app supported system that helps health systems identify and better manage people at high risk of cardiovascular disease has been shown to improve the use of appropriate medications and lower blood pressure in rural Indonesian communities. The application was developed in Australia and piloted in India with great success and is now being taken to other countries.